Stock BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BioForce Nanosciences Holdings, Inc.

Equities

BFNH

US09064C2061

Market Closed - OTC Markets
Other stock markets
 10:33:02 2024-05-29 EDT 		5-day change 1st Jan Change
1.21 USD -3.20% Intraday chart for BioForce Nanosciences Holdings, Inc. +10.00% -39.80%
05-03 BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-01 BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
CI
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
AQ
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
CI
BIOFORCE NANOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
BioForce Nanosciences Holdings, Inc. Announces CEO Changes
CI
BioForce Nanosciences Holdings, Inc. Appoints Sasha Shapiro as President, Effective November 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BFNH Stock
  4. News BioForce Nanosciences Holdings, Inc.